Department Nursing and Podiatry, Faculty of Health Sciences, University of Malaga, Arquitecto Francisco Peñalosa 3, Ampliación de Campus de Teatinos, 29071 Málaga, Spain.
Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain.
Int J Environ Res Public Health. 2021 Apr 30;18(9):4791. doi: 10.3390/ijerph18094791.
Kinesiophobia can be an obstacle to physical and motor activity in patients with Parkinson's disease (PD). PD affects patients' independence in carrying out daily activities. It also impacts a patient's biopsychosocial well-being. The objective of this study was to analyze the levels and scores of kinesiophobia in PD patients and compare them with healthy volunteers.
We deployed a case-control study and recruited 124 subjects (mean age 69.18 ± 9.12). PD patients were recruited from a center of excellence for Parkinson's disease (cases n = 62). Control subjects were recruited from the same hospital (control n = 62). Kinesiophobia total scores and categories were self-reported using the Spanish version of the Tampa Scale of Kinesiophobia (TSK-11).
Differences between cases and control groups were analyzed using the Mann-Whitney U test. Statistically significant differences ( < 0.05) were shown between groups when comparing kinesiophobia categories (or levels) and total scores, revealing higher kinesiophobia symptoms and levels in PD patients. All of the PD patients reported some degree of kinesiophobia (TSK-11 ≥ 18), while the majority of PD patients (77.3%) had kinesiophobia scores rated as moderate to severe (TSK-11 ≥ 25). On the other hand, ~45.1% of controls reported no or slight kinesiophobia and 53.2% reported moderate kinesiophobia.
Total kinesiophobia scores were significantly higher in PD patients compared with healthy controls, with moderate to severe kinesiophobia levels prevailing in PD patients. Therefore, individuals living with PD should be evaluated and controlled in order to detect initial kinesiophobia symptoms.
恐动症可能是帕金森病（PD）患者进行身体和运动活动的障碍。PD 影响患者进行日常活动的独立性，也影响患者的生物心理社会福祉。本研究的目的是分析 PD 患者的恐动症水平和评分，并将其与健康志愿者进行比较。
我们进行了病例对照研究，共招募了 124 名受试者（平均年龄 69.18±9.12 岁）。PD 患者从帕金森病卓越中心招募（病例组 n=62）。对照组从同一家医院招募（对照组 n=62）。使用西班牙语版 Tampa 运动恐惧量表（TSK-11）自我报告恐动症总分和类别。
使用 Mann-Whitney U 检验分析病例组和对照组之间的差异。当比较恐动症类别（或水平）和总分时，两组之间显示出统计学上的显著差异（<0.05），表明 PD 患者的恐动症症状和水平更高。所有 PD 患者都报告了某种程度的恐动症（TSK-11≥18），而大多数 PD 患者（77.3%）的恐动症评分评定为中度至重度（TSK-11≥25）。另一方面，约 45.1%的对照组报告无或轻度恐动症，而 53.2%报告中度恐动症。
与健康对照组相比，PD 患者的总恐动症评分明显更高，PD 患者中存在中度至重度恐动症。因此，应评估和控制患有 PD 的个体，以发现初始的恐动症症状。
